Call (289) 812-0046
Clinical Trial
For adults (≥18) with moderate to severe plaque psoriasis (subcutaneous study drug)
CLINICAL TRIAL
RECRUITING
Trial ID: NCT06550076
Phase 3 | Oral tablet | 52 weeks